Immunotherapy for Atherosclerosis—Novel Concepts

Sabine Steffens; Christian Weber

doi:10.1055/s-0039-1683451

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2019; 119(04): 515-516
DOI: 10.1055/s-0039-1683451

Theme Issue Editorial Focus

Georg Thieme Verlag KG Stuttgart · New York

Immunotherapy for Atherosclerosis—Novel Concepts

Sabine Steffens

¹Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximilians-University (LMU) Munich, Munich, Germany

²German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany

,

Christian Weber

²German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany

³Department of Biochemistry, Cardiovascular Research Institute, Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands

References
1 Organization WH. Cardiovascular diseases (CVDs). Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) . Accessed February 25, 2019
2 Kaltner H, Gabius HJ. Sensing glycans as biochemical messages by tissue lectins: the sugar code at work in vascular biology. Thromb Haemost 2019;
3 Grewal PK, Uchiyama S, Ditto D. , et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 2008; 14 (06) 648-655
4 Sinitski D, Kontos C, Krammer C, Asare Y, Kapurniotu A, Bernhagen J. Macrophage migration inhibitory factor (MIF)-based therapeutic concepts in atherosclerosis and inflammation. Thromb Haemost 2019;
5 Gencer S, van der Vorst EPC, Aslani M, Weber C, Döring Y, Duchene J. Atypical chemokine receptors in cardiovascular disease. Thromb Haemost 2019;
6 Mahalingam D, Patel M, Sachdev J. , et al. PD-011: Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC). Ann Oncol 2016; 27 (Suppl. 02) ii105-ii
7 Van Avondt K, van der Linden M, Naccache PH, Egan DA, Meyaard L. Signal inhibitory receptor on leukocytes-1 limits the formation of neutrophil extracellular traps, but preserves intracellular bacterial killing. J Immunol 2016; 196 (09) 3686-3694
8 Guillamat-Prats R, Rami M, Herzig S, Steffens S. Endocannabinoid signalling in atherosclerosis and related metabolic complications. Thromb Haemost 2019;
9 World Health Organization. Obesity and overweight. Available at: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
10 Ridker PM, Everett BM, Thuren T. , et al; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377 (12) 1119-1131